Skip to content

Achieve Life Sciences ACHV Granted (in shares)

Granted (in shares) at other companies

Repligen logo
RepligenRGEN
$125.03
Genpact logo
GenpactG
$0.00
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$10.29
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$32.52
Wingstop logo
WingstopWING
$0.00
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$34.31+175%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's granted (in shares)?
Achieve Life Sciences (ACHV) reported granted (in shares) of $4.36 in Q1 2026.
How has Achieve Life Sciences's granted (in shares) changed year-over-year?
Achieve Life Sciences's granted (in shares) increased by 32.1% year-over-year, from $3.30 to $4.36.
What does granted (in shares) mean?
The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.